BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28586413)

  • 21. Impact of baseline tricuspid regurgitation on long-term clinical outcomes and survival after interventional edge-to-edge repair for mitral regurgitation.
    Schueler R; Öztürk C; Sinning JM; Werner N; Welz A; Hammerstingl C; Nickenig G
    Clin Res Cardiol; 2017 May; 106(5):350-358. PubMed ID: 27999930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
    Bouleti C; Chauvet M; Franchineau G; Himbert D; Iung B; Alos B; Brochet E; Urena M; Ghodbane W; Ou P; Provenchere S; Nataf P; Vahanian A
    Eur J Cardiothorac Surg; 2017 Jan; 51(1):80-88. PubMed ID: 27582074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sutureless aortic valve replacement may improve early mortality compared with transcatheter aortic valve implantation: A meta-analysis of comparative studies.
    Takagi H; Umemoto T;
    J Cardiol; 2016 Jun; 67(6):504-12. PubMed ID: 26476500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Right Ventricular Dysfunction and Tricuspid Regurgitation on Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Schwartz LA; Rozenbaum Z; Ghantous E; Kramarz J; Biner S; Ghermezi M; Shimiaie J; Finkelstein A; Banai S; Aviram G; Ingbir M; Keren G; Topilsky Y
    J Am Soc Echocardiogr; 2017 Jan; 30(1):36-46. PubMed ID: 27742242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valves in 100 consecutive patients.
    Schäfer U; Deuschl F; Schofer N; Frerker C; Schmidt T; Kuck KH; Kreidel F; Schirmer J; Mizote I; Reichenspurner H; Blankenberg S; Treede H; Conradi L
    Int J Cardiol; 2017 Apr; 232():247-254. PubMed ID: 28118931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worse survival after transcatheter aortic valve implantation than surgical aortic valve replacement: A meta-analysis of observational studies with a propensity-score analysis.
    Takagi H; Umemoto T;
    Int J Cardiol; 2016 Oct; 220():320-7. PubMed ID: 27390949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
    O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MitraClip and Transcatheter Aortic Valve Implantation (TAVI): State of the Art 2015.
    Candreva A; Maisano F; Taramasso M
    Curr Heart Fail Rep; 2015 Dec; 12(6):379-88. PubMed ID: 26472189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reverse Cardiac Remodeling After Transcatheter Treatment of Severe Tricuspid Regurgitation Using the Edge-to-Edge MitraClip Technique.
    Ledwoch J; Fellner C; Poch F; Schlatterbeck L; Dommasch M; Dirschinger R; Stundl A; Laugwitz KL; Kupatt C; Hoppmann P
    J Invasive Cardiol; 2019 Apr; 31(4):89-93. PubMed ID: 30927530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit.
    Mohammed S; El-Menyar A; Al-Janubi H; Shabana A; Alanazi Z
    Curr Vasc Pharmacol; 2018 Jan; 16(2):107-113. PubMed ID: 28393705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Persistent Tricuspid Regurgitation After Transcatheter Aortic Valve Replacement in Patients With Baseline Tricuspid Regurgitation.
    Worku B; Valovska MT; Elmously A; Kampaktsis P; Castillo C; Wong SC; Salemi A
    Innovations (Phila); 2018; 13(3):190-199. PubMed ID: 29912741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Tricuspid Valve Regurgitation on Early Outcomes after Transcatheter Aortic Valve Replacement.
    Barvalia M; Tayal R; Cohen M; Miguel Amor M; Tcharnaia L; Chen C; Russo M; Haik B
    J Heart Valve Dis; 2017 Jul; 26(4):380-385. PubMed ID: 29302936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right ventricular dysfunction and tricuspid regurgitation in functional mitral regurgitation.
    Truong VT; Ngo TNM; Mazur J; Nguyen HTM; Pham TTM; Palmer C; Pham KNP; Phan HT; Lee KS; Bannehr M; Butter C; Gyoten T; Chung ES
    ESC Heart Fail; 2021 Dec; 8(6):4988-4996. PubMed ID: 34551208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-Term Clinical Outcomes of Transcatheter Tricuspid Valve Repair With the Third-Generation MitraClip XTR System.
    Ruf TF; Hahn RT; Kreidel F; Beiras-Fernandez A; Hell M; Gerdes P; da Roche E Silva JG; Vosseler M; Geyer M; Tamm A; Münzel T; von Bardeleben RS
    JACC Cardiovasc Interv; 2021 Jun; 14(11):1231-1240. PubMed ID: 34112460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre- and postoperative tricuspid regurgitation in patients with severe symptomatic aortic stenosis: importance of pre-operative tricuspid annulus diameter.
    Dumont C; Galli E; Oger E; Fournet M; Flecher E; Leclercq C; Verhoye JP; Donal E
    Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):319-328. PubMed ID: 28329333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk.
    Schymik G; Heimeshoff M; Bramlage P; Herbinger T; Würth A; Pilz L; Schymik JS; Wondraschek R; Süselbeck T; Gerhardus J; Luik A; Gonska BD; Tzamalis P; Posival H; Schmitt C; Schröfel H
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):738-44. PubMed ID: 25641398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First percutaneous Micra leadless pacemaker implantation and tricuspid valve repair with MitraClip NT for lead-associated severe tricuspid regurgitation.
    Tang GH; Kaple R; Cohen M; Dutta T; Undemir C; Ahmad H; Poniros A; Bennett J; Feng C; Lansman S
    EuroIntervention; 2017 Feb; 12(15):e1845-e1848. PubMed ID: 28117279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter aortic valve implantation: where are we now?
    Mariathas M; Rawlins J; Curzen N
    Future Cardiol; 2017 Nov; 13(6):551-566. PubMed ID: 29064293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry.
    Puls M; Lubos E; Boekstegers P; von Bardeleben RS; Ouarrak T; Butter C; Zuern CS; Bekeredjian R; Sievert H; Nickenig G; Eggebrecht H; Senges J; Schillinger W
    Eur Heart J; 2016 Feb; 37(8):703-12. PubMed ID: 26614824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary review of percutaneous therapy for tricuspid valve regurgitation.
    Nagaraja V; Kapadia SR; Miyasaka R; Harb SC; Krishnaswamy A
    Expert Rev Cardiovasc Ther; 2020 Apr; 18(4):209-218. PubMed ID: 32248715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.